Sipai Health Technology Co., Ltd. (HKG: 0314), operating as Medbanks, announced the acquisition of 100% stakes in Jianyi Tech, a commercial insurance technology firm, for RMB 360 million (USD 52 million). The transaction bolsters Medbanks’ “Insurance + Medical Health + Technology” ecosystem, integrating Jianyi’s intelligent cloud platform and nationwide pharmaceutical service network serving 200+ insurance companies and 2,000 medium-to-large enterprises.
Strategic Optionality: Asset provides infrastructure for potential captives/self-insurance products and pharmacy benefit management (PBM) expansion
Forward‑Looking Statements This brief contains forward‑looking statements regarding integration execution, revenue synergies, and market expansion for the Medbanks-Jianyi Tech combination. Actual results may differ due to enterprise client retention, technology integration challenges, and regulatory developments affecting commercial health insurance in China.-Fineline Info & Tech
Insight, China's Pharmaceutical Industry Fineline Info & Tech is a comprehensive global pharmaceutical database that spans the entire product lifecycle. Its mission is to equip professionals and executives across all sectors of the life sciences industry with a standardized data language, offering a holistic view of the Chinese pharmaceutical competitive landscape. Flcube.com furnishes critical data essential for informed decision-making, drawing on global industry news, policy insights, competitive intelligence, and advanced analytical tools.
